and glucocorticoids. Methotrexate is considered more effective than trimethoprim/sulfamethoxazole for remission induction, based on previous findings Remission maintenance Recommendation: For patients with severe GPA/MPA whose disease has entered remission after treatment with cyclophosphamide or rituximab, we conditionally recommend treatment with rituximab over methotrexate or azathioprine for remission maintenance. Rituximab is associated with a lower relapse rate than azathioprine when used